OFFICIAL PUBLICATION OF

by its subsidiary APPco

Posts in tag

Zepbound

News

FDA approves new ‘King Kong’ weight loss drug

Potential blockbuster dubbed Zepbound to join cousin drug Mounjaro on US market Tirzepatide, Eli Lilly’s GIP and GLP-1 agonist, described by media as “the King Kong of drugs”, has been …

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Wesfarmers targets affordable healthcare

When healthcare is treated as a commodity and patients regarded as consumers, health outcomes are compromised and overall healthcare spending…

Edward Hatfield

Zepbound

FDA approves new ‘King Kong’ weight loss drug

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

FDA approves new ‘King Kong’ weight loss drug

MENU

Hi there! 👋 Looks like you’re not logged in.